Form 4: Axon Enterprise Director Jeri Williams Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


Director Jeri Williams sold 110 shares of Axon Enterprise, Inc. common stock on September 30, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • On September 30, 2024, Jeri Williams, a director of Axon Enterprise, Inc., sold 110 shares of common stock at a price of $400.
  • The sale was executed under a Rule 10b5-1 trading plan adopted on May 23, 2024.
  • Following the transaction, Williams directly owns 1,934 shares of Axon Enterprise, Inc.
  • The transaction was reported on a Form 4 filed with the Securities and Exchange Commission on October 1, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged plan. It doesn't indicate any positive or negative outlook for the company.

Positives

  • The sale was conducted under a pre-arranged 10b5-1 trading plan, which can mitigate concerns about insider trading.

Industry Context

Sales by insiders are a normal part of corporate activity. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific non-public information.

Stakeholder Impact

  • The sale of shares by a director could have a minor impact on shareholder sentiment, but the existence of a 10b5-1 plan mitigates concerns.

Key Dates

DateDescription
2024-05-23Date the reporting person adopted the Rule 10b5-1 trading plan
2024-09-30Date of the transaction (sale of shares)
2024-10-01Date the Form 4 was signed

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.